Filing Details
Dare Bioscience, Inc. (NASDAQ:DARE) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedNASDAQ:DARE
Dare Bioscience, Inc. (DARE) Reports Material Event to SEC
Filing Details Dare Bioscience, Inc. (NASDAQ:DARE) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market Context Dare…
Market Context
Dare Bioscience, Inc.'s stock currently trades at $2.09 with a market capitalization of $19.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Dare Bioscience, Inc.'s stock.
All SEC filings for Dare Bioscience, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DARE Stock Page
Frequently Asked Questions
Where can I read DARE's SEC filings?
Browse all filings on our DARE SEC filings page.
What types of SEC filings does Dare Bioscience, Inc. file?
Public companies like Dare Bioscience, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.